Vitality male enhancement dietary supplement capsules

No lo uses. Devuélvelo a la tienda o bótalo. Si te sentiste mal después de usarlo, llama a tu médico y dile qué tomaste.

El aviso no da tamaños, fechas ni lotes. Compara la marca y el producto con el aviso oficial.

One Source Nutrition retiró este producto. Motivo: Contiene un medicamento no aprobado.

Risk Statement: Consumption of products with undeclared tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk. To date, One Source Nutrition, Inc. has not received any reports of adverse events related to this recall.

Tiene un medicamento que no aparece en la etiqueta. Puede ser peligroso, sobre todo si tomas otras medicinas.

En todo EE. UU. (distribución nacional). El aviso no nombra Puerto Rico, pero pudo haber llegado aquí.

Según el aviso: Vitality capsules was distributed Nationwide to retail outlets from wholesale distributor. Consumers should return all purchased product to place of purchase. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch…

FDA recall announcement: One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil Company: One Source Nutrition Product: Vitality male enhancement dietary supplement capsules (brand: Vitality) Reason: Undeclared Sildenafil and Tadalafil [Unapproved Drug] Distribution: Vitality capsules was distributed Nationwide to retail outlets from wholesale distributor. Consumers should return all purchased product to place of purchase. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting